You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-c-Kit-M4205
M4205

Chemical Structure : M4205

CAS No.: 2590556-80-0

M4205 (IDRX-42)

Catalog No.: PC-20159Not For Human Use, Lab Use Only.

M4205 (IDRX-42) is a potent, highly selective inhibitor of KIT mutations with cell IC50 of 52 nM on cKIT autophosphorylation in the GIST430/654 cell line.

Packing Price Stock Quantity
5 mg $158 In stock
10 mg $248 In stock
25 mg $428 In stock
50 mg $728 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

M4205 (IDRX-42) is a potent, highly selective inhibitor of KIT mutations with cell IC50 of 52 nM on cKIT autophosphorylation in the GIST430/654 cell line.
M4205 inhibits KIT autophosphorylation at Y703 in the imatinib sensitive GIST430 cell line with an IC50 value of 4 nM.
M4205 inhibits the imatinib-resistant cell line GIST430/654 (exon 11 and exon 13 mutation) and the AML cell line Kasumi-1 (exon 17 mutation N822 K) with IC50 values of 48 and 4 nM, respectively.
M4205 displays high selectivity in a biochemical panel of 398 kinases at 1uM, only inhibits PDGFRA, PDGFRB, KIT (wt), FLT3, CSF1R, and lymphocyte-specific protein tyrosine kinase (LCK) with >80% inhibtion.
M4205 also displays high cellular kinase selectivity at 1 μM using a panel of NanoBRET assays, only bindsto KIT (wt) and FLT3 with 65% and 45% occupancy.
M4205 (35 mg/kg) showed strong in vivo tumor growth inhibition and led to regression in mice bearing GIST430/654 tumor, with dose- and exposure-dependent inhibition of KIT autophosphorylation.

Physicochemical Properties

M.Wt 508.63
Formula C29H32N8O
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(4-(1-methyl-1H-pyrazol-4-yl)benzyl)-6-(7-(3-(pyrrolidin-1-yl)propoxy)imidazo[1,2-a]pyridin-3-yl)pyrimidin-4-amine

References

1. Andreas Blum, et al. J Med Chem. 2023 Feb 23;66(4):2386-2395.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: